Study on miRNA-146a-5p rs2910164 polymorphism in attention deficit and hyperactive disorder occurrence and development.

doi:10.1080/17410541.2026.2634610

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Study on miRNA-146a-5p rs2910164 polymorphism in attention deficit and hyperactive disorder occurrence and development.

Personalized medicine - 1 Feb 2026

Zhuang Wenmin, Ding Xuemin, Luo Haixia, Deng Ludan

Abstract excerpt

OBJECTIVES: This study investigated the role of miR-146a-5p rs2910164 polymorphism in attention deficit hyperactivity disorder (ADHD). METHODS: This study included 180 ADHD children and 122 healthy individuals aged 6-12 years. The ADHD children were hospitalized for treatment while healthy individuals were recruited from a local primary school. ADHD patients received 24-week MPH administration, and treatment...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Attention Deficit Disorder with Hyperactivity

Share to Case-Control Studies

Share to Child

Share to Genetic Predisposition to Disease

Share to MicroRNAs

Share to Polymorphism, Single Nucleotide

Share to Risk Factors

Source

Open in PubMed

Identifiers

PMID: 41784178
DOI: 10.1080/17410541.2026.2634610

Genes

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Study on miRNA-146a-5p rs2910164 polymorphism in attention deficit and hyperactive disorder occurrence and development.PMID 41784178Read ↗

Blood-Bourne MicroRNA Biomarker Evaluation in Attention-Deficit/Hyperactivity Disorder of Han Chinese Individuals: An Exploratory StudySemantic proximity Read ↗

MicroRNAs serve as prediction and treatment-response biomarkers of attention-deficit/hyperactivity disorder and promote the differentiation of neuronal cells by repressing the apoptosis pathwaySemantic proximity Read ↗

Evaluation of single nucleotide polymorphisms in the miR-183-96-182 cluster in adulthood attention-deficit and hyperactivity disorder (ADHD) and substance use disorders (SUDs).Semantic proximity Read ↗

Attention-deficit hyperactivity disorder in adults: A systematic review and meta-analysis of genetic, pharmacogenetic and biochemical studies.Semantic proximity Read ↗

Regulating the Regulators in Attention-Deficit/Hyperactivity Disorder: A Genetic Association Study of microRNA Biogenesis Pathways.Semantic proximity Read ↗

The Computational Analysis Conducted on miRNA Target Sites in Association with SNPs at 3'UTR of ADHD-implicated Genes.Semantic proximity Read ↗

Candidate Gene Expression Investigation in Children With Attention Deficit Hyperactivity DisorderSemantic proximity Read ↗

SLC6A1 gene involvement in susceptibility to attention-deficit/hyperactivity disorder: A case-control study and gene-environment interaction.Semantic proximity Read ↗

Attention-deficit/hyperactive disorder updatesSemantic proximity Read ↗

A functional variant in SLC1A3 influences ADHD risk by disrupting a hsa‐miR‐3171 binding site: A two‐stage association studySemantic proximity Read ↗

Preliminary evidence for association of genetic variants in pri-miR-34b/c and abnormal miR-34c expression with attention deficit and hyperactivity disorder.Semantic proximity Read ↗

Correlation research of susceptibility single nucleotide polymorphisms and the severity of clinical symptoms in attention deficit hyperactivity disorderSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.